Percutaneous mitral valve therapy: when? Which patients?

摘要: Purpose of review Transcatheter management valvular heart disease is an emerging area intense interest. Patients with mitral regurgitation present a large clinical unmet need for therapeutic advances. Recent findings A randomized, pivotal trial one device, which performs edge-to-edge repair, has recently completed enrolment and awaiting all patients to reach the primary endpoint. host other devices are still in preclinical or early feasibility trials after having undergone device iteration. Clinical two have been stopped because disappointing results. Summary Although field transcatheter treatment aortic stenosis proceeding at brisk pace commercial approval Europe, percutaneous progressed much more measured varying cause disease, complexity anatomy, imaging, delivery issues.